SHub Reaper | macOS Stealer Spoofs Apple, Google, and Microsoft in a Single Attack Chain sentinelone.com
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
